Eisai Inc., the U.S. pharmaceutical subsidiary of Japan headquartered Eisai Co., Ltd., has announced the immediate appoi...
Takeda Pharmaceutical and Frazier Healthcare Partners have announced a collaboration to launch Phathom Pharmaceuticals, ...
Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, w...
Japanese pharma company Daiichi Sankyo has announced that the Company has been unable to fulfill its obligation to build...
Eisai Co., Ltd. announced that presentations on a series of abstracts highlighting updates regarding its in-house discov...
Teijin Limited has announced that it has signed a research and development agreement with the Japan Agency for Medical R...
Takeda Pharmaceutical Company has announced that the U.S. Food & Drug Administration (FDA) has accepted for rev...
Daiichi Sankyo has announced the launch in Japan of MINNEBRO® Tablets 1.25 mg, 2.5 mg and 5 mg (generic name: e...
Eisai Co., Ltd. has entered into a license agreement with medac Gesellschaft für klinische Spezialpräparate mb...
Japan headquartered Takeda Pharma has entered into an agreement to sell TachoSil®, a surgical patch designed to achi...
Novartis announced that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the asset...
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a ...
Promethera Biosciences, a global innovator in cell-based medicines and liver diseases has announced the closing of a &eu...
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal...
Eisai Co., Ltd. and the UK Dementia Research Institute (UK DRI) announced the launch of a joint post-doctoral programme ...
US based Skyhawk Therapeutics, Inc. has announced a strategic collaboration with Japan headquartered Takeda Pharmaceutic...
Takeda has announced the opening of a new research facility in San Diego, California. Extending Takeda’s 14-year p...
Global biopharmaceutical company Takeda announced Andrey Potapov as its Area Head for India, CIS (the Commonwealth of In...
